National Cancer Institute
NCI is exploring, developing, and sharing significant new cutting-edge technologies that will continue the transformation of our understanding of cancer and how to address it, and help usher in the cancer clinical practice of tomorrow. These efforts include constructing the first of its kind informational infrastructure to link the diverse elements of the cancer community together in one united effort, exploring nanotechnology-based diagnosis and treatment possibilities, and finding new ways to image cancer at the subcellular level.
New Technologies for Cancer Research
Cancer Biomedical Informatics Grid (caBIGTM): As we begin to better understand cancer at the molecular level and personalized medicine becomes a reality in cancer patient care, researchers and clinicians will require more rapid access to—and easier methods to analyze and utilize—the multiple types of information involved. Earlier systems to help translate the necessary data into better patient outcomes were disconnected or underperforming. caBIGTM serves as the cornerstone of NCI's biomedical informatics efforts to transform cancer tools and capabilities that span the entire continuum of clinical research, pathology and genomics, and more are under development. These tools, though developed for the cancer research effort, are already widely applicable beyond the cancer community.
The NCI Alliance for Nanotechnology in Cancer: NCI is engaged in efforts to harness the power of nanotechnology—the field of research that deals with the engineering and creation of things from materials that are less than 100 nanometers (one-billionth of a meter) in size—to radically change the way we diagnose, treat, and prevent cancer. The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer. New nanotechnology approaches carry the potential to enable a new generation of targeted diagnostics, therapeutics, and preventives. Through the networked efforts of researchers at eight designated Centers of Cancer Nanotechnology Excellence, and the NCI's Nanotechnology Characterization Laboratory (NCL) at its NCI-Frederick facility, NCI is helping build the cancer medicine of the future using technology developed today.
Back to Top Previous Page Next Page
